More recently, patients who are postmenopausal also have been offered the option of taking an aromatase inhibitor AI as an alternative to tamoxifen or in sequence after tamoxifen

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

A phase II III trial presented by Unno et al at the 2019 Gastrointestinal Cancers Symposium Abstract 189 sought to compare neoadjuvant chemotherapy using gemcitabine and the oral fluoropyrimidine combination of tegafur gimeracil oteracil S 1 to upfront surgery in patients with histologic